Endometrial Response to Raloxifene Compared with Placebo, Cyclical Hormone Replacement Therapy, and Unopposed Estrogen in Postmenopausal Women

Abstract

Raloxifene 60 mg/day for up to 30 months is not associated with vaginal bleeding or increased endometrial thickness in postmenopausal women.